Clinical Trial Update: Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pyronaridine in acute myeloid leukemia and acute lymphoblastic leukemia is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Pyronaridine (pyronaridine)

Snippet

Sponsor: Armaceutica, Inc. | Conditions: Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) | Phase 2 | Status: UNKNOWN